Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy

Gil Moravsky1, Beata Bruchal-Garbicz, Michal Jamorski

  • 1Division of Cardiology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.

Insights

Septal myectomy significantly improves symptoms and reduces obstruction in hypertrophic obstructive cardiomyopathy (HOCM) patients. Post-surgery, myocardial mechanics show reduced circumferential strain and normalized rotation, indicating improved cardiac function.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomedical Engineering

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) presents abnormal myocardial mechanics, including low longitudinal strain and high circumferential strain.
  • Septal myectomy is a standard procedure for symptomatic HOCM patients, aiming for symptomatic relief.

Purpose of the Study:

  • To investigate the association between functional improvement after septal myectomy and changes in myocardial mechanics in HOCM patients.
  • To assess alterations in longitudinal strain, circumferential strain, and rotation post-myectomy.

Main Methods:

  • Retrospective analysis of clinical data and echocardiographic studies from 66 HOCM patients before and after septal myectomy (6-18 months).
  • Assessment of myocardial mechanics, including strain and rotation, using two-dimensional strain software (Velocity Vector Imaging).

Main Results:

  • Significant symptomatic improvement (NYHA class) and reduction in left ventricular outflow tract gradient and left atrial volume index post-myectomy.
  • Global longitudinal strain remained unchanged, while circumferential strain decreased and left ventricular twist normalized.
  • Predictors of symptomatic response included younger age, thinner posterior wall, and higher lateral early diastolic velocity (e').

Conclusions:

  • Septal myectomy effectively alleviates symptoms, reduces obstruction, and improves cardiac mechanics in HOCM.
  • Observed changes in myocardial mechanics (decreased circumferential strain, normalized rotation) reflect adaptations to reduced afterload.
  • Factors like age, posterior wall thickness, and diastolic function influence the degree of symptomatic response to myectomy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...